고범석
#수술후퇴원클리닉#유방암진료#유방암 미용수술
|
학력
2010 .03 ~ 2013 .02울산대학교 의학 박사
2002 .03 ~ 2004 .02조선대학교 의학 석사
1994 .03 ~ 2000 .02조선대학교 의학 학사
2002 .03 ~ 2004 .02조선대학교 의학 석사
1994 .03 ~ 2000 .02조선대학교 의학 학사
경력
2015 .03 ~ 현재서울아산병원 유방외과 임상부교수
2010 .03 ~ 2015 .02서울아산병원 유방외과 임상조교수
2008 .05 ~ 2010 .02서울아산병원 유방외과 임상강사
2005 .04 ~ 2008 .04평택안중백병원 외과 과장
2001 .03 ~ 2005 .02조선대학교병원 전공의
2000 .03 ~ 2001 .02조선대학교병원 인턴
2010 .03 ~ 2015 .02서울아산병원 유방외과 임상조교수
2008 .05 ~ 2010 .02서울아산병원 유방외과 임상강사
2005 .04 ~ 2008 .04평택안중백병원 외과 과장
2001 .03 ~ 2005 .02조선대학교병원 전공의
2000 .03 ~ 2001 .02조선대학교병원 인턴
논문
A retrospective prognostic evaluation analysis using the 8th edition of the American Joint Committee on Cancer staging system for breast cancer.
Characteristics and prognosis of breast cancer after liver or kidney transplantation.
Comparing Accuracy of Mammography and Magnetic Resonance Imaging for Residual Calcified Lesions in Breast Cancer Patients Undergoing Neoadjuvant Systemic Therapy.
No Association of Positive Superficial and/or Deep Margins with Local Recurrence in Invasive Breast Cancer Treated with Breast-Conserving Surgery.
Novel cancer gene variants and gene fusions of triple-negative breast cancers (TNBCs) reveal their molecular diversity conserved in the patient-derived xenograft (PDX) model.
Ectopic Male Breast Cancer in the Perineum: A Case Report.
Impact of pathologic diagnosis of internal mammary lymph node metastasis in clinical N2b and N3b breast cancer patients.
Interaction between body mass index and hormone-receptor status as a prognostic factor in lymph-node-positive breast cancer.
Survival improvement in hormone-responsive young breast cancer patients with endocrine therapy.
Survival Outcome of Combined GnRH Agonist and Tamoxifen Is Comparable to That of Sequential Adriamycin and Cyclophosphamide Chemotherapy Plus Tamoxifen in
Premenopausal Patients with Lymph-Node-Negative, Hormone-Responsive, HER2-Negative, T1-T2 Breas
Concurrent Gonadotropin-Releasing Hormone Agonist Administration with Chemotherapy Improves Neoadjuvant Chemotherapy Responses in Young Premenopausal Breast Cancer Patients.
Genetic polymorphism of ESR1 rs2881766 increases breast cancer risk in Korean women
Metformin increases survival in hormone receptor-positive, HER2-positive breast cancer patients with diabetes
Patient reporting pain intensity immediately after surgery can be associated with underlying depression in women with breast cancer
The Basic Facts of Korean Breast Cancer in 2012: Results from a Nationwide Survey and Breast Cancer Registry Database.
Changes in serum hydroxyvitamin D levels of breast cancer patients during tamoxifen treatment or chemotherapy in premenopausal breast cancer patients
Daily collection of self-reporting sleep disturbance data via a smartphone app in breast cancer patients receiving chemotherapy: a feasibility study
Diagnostic performance of breast-specific gamma imaging in the assessment of residual tumor after neoadjuvant chemotherapy in breast cancer patients
Large genomic rearrangement of BRCA1 and BRCA2 genes in familial breast cancer patients in Korea.
Preoperative serum HER2 extracellular domain levels in primary invasive breast cancer
Characteristics and prognosis of breast cancer after liver or kidney transplantation.
Comparing Accuracy of Mammography and Magnetic Resonance Imaging for Residual Calcified Lesions in Breast Cancer Patients Undergoing Neoadjuvant Systemic Therapy.
No Association of Positive Superficial and/or Deep Margins with Local Recurrence in Invasive Breast Cancer Treated with Breast-Conserving Surgery.
Novel cancer gene variants and gene fusions of triple-negative breast cancers (TNBCs) reveal their molecular diversity conserved in the patient-derived xenograft (PDX) model.
Ectopic Male Breast Cancer in the Perineum: A Case Report.
Impact of pathologic diagnosis of internal mammary lymph node metastasis in clinical N2b and N3b breast cancer patients.
Interaction between body mass index and hormone-receptor status as a prognostic factor in lymph-node-positive breast cancer.
Survival improvement in hormone-responsive young breast cancer patients with endocrine therapy.
Survival Outcome of Combined GnRH Agonist and Tamoxifen Is Comparable to That of Sequential Adriamycin and Cyclophosphamide Chemotherapy Plus Tamoxifen in
Premenopausal Patients with Lymph-Node-Negative, Hormone-Responsive, HER2-Negative, T1-T2 Breas
Concurrent Gonadotropin-Releasing Hormone Agonist Administration with Chemotherapy Improves Neoadjuvant Chemotherapy Responses in Young Premenopausal Breast Cancer Patients.
Genetic polymorphism of ESR1 rs2881766 increases breast cancer risk in Korean women
Metformin increases survival in hormone receptor-positive, HER2-positive breast cancer patients with diabetes
Patient reporting pain intensity immediately after surgery can be associated with underlying depression in women with breast cancer
The Basic Facts of Korean Breast Cancer in 2012: Results from a Nationwide Survey and Breast Cancer Registry Database.
Changes in serum hydroxyvitamin D levels of breast cancer patients during tamoxifen treatment or chemotherapy in premenopausal breast cancer patients
Daily collection of self-reporting sleep disturbance data via a smartphone app in breast cancer patients receiving chemotherapy: a feasibility study
Diagnostic performance of breast-specific gamma imaging in the assessment of residual tumor after neoadjuvant chemotherapy in breast cancer patients
Large genomic rearrangement of BRCA1 and BRCA2 genes in familial breast cancer patients in Korea.
Preoperative serum HER2 extracellular domain levels in primary invasive breast cancer
저서
유방암 환자를 위한 치료 안내서 5판
보도자료
유방암’ 유두는 암 재발률과 관계 없다
http://www.bosa.co.kr/news/articleView.html?idxno=2116015
[명의에게 묻다] 생존율 높아진 유방암, '감쪽같은' 수술 가능할까?
https://www.yna.co.kr/view/AKR20171017157700017?input=1195m
[건강 팁] 유방암 예방법
https://www.sedaily.com/NewsView/1OL4ZPHY6H
http://www.bosa.co.kr/news/articleView.html?idxno=2116015
[명의에게 묻다] 생존율 높아진 유방암, '감쪽같은' 수술 가능할까?
https://www.yna.co.kr/view/AKR20171017157700017?input=1195m
[건강 팁] 유방암 예방법
https://www.sedaily.com/NewsView/1OL4ZPHY6H
포스팅
Clinicopathologic Characteristics and Prognostic factors of pure mucinous breast cancer
The patient underwent axillary lymph node dissection was treated with a mixture of Poloxamer and Alginate (Guardix-SG®) Impact on range of action: Single-institution, prospective, randomized, double-blind investigator pilot study
Analysis of serial circulating tumor cell count during neoadjuvant systemic therapy in breast cancer patients
Clinicopathologic Characteristics and Prognostic factors of pure mucinous breast cancer
THE CLINICAL SIGNIFICANCE OF ANTI-MULLERIAN HORMONE EVALUATION IN BREAST CANCER PATIENTS WHO ARE TAKING TAMOXIFEN.
Screening for Psychological Distress in Breast Cancer Patients and Psychiatric Referral acceptance among Screen Positive Patients
A Nomogram for Predicting the Oncotype DX Recurrence Score in Women with T1-3N0-1miM0 Hormone Receptor-positive, Human Epidermal Growth Factor-2 (HER2)-negative Breast Cancer
Evaluation of Surgical Guides Using a 3D Printer in Breast Cancer Patients Who Received Neoadjuvant Chemotherapy
No negative effect of short-term delays in surgery on tumor progression and survival outcomes in invasive breast cancer.
CHEMOTHERAPY FOR NODE-NEGATIVE, HORMONE RECEPTOR-POSITIVE MUCINOUS CARCINOMA OF BREAST
Breast-specific gamma imaging versus magnetic resonance imaging in ductal carcinoma in situ: A prospective head-to-head trial
Neutrophil lymphocyte ratio(NLR) change after systemic treatment can be a predictive factor of cancer specific survival(CSS) in stage lV breast cancer.
Poor survival of the young breast cancer is due to early and late recurrence in non triple negative breast cancer
Multiple Primary Cancers in Breast Cancer Patients
Discordance of hormone receptor and human epidermal growth factor receptor2 as a prognostic factor of survival between primary breast cancer and recurrent breast cancer.
Heterogeneity of Reproductive Risk Factors for Breast Cancer According to Age and Tumor Subtype
Diagnostic performance of breast scintigraphy with breast-specific gamma camera in the assessment of residual tumor after neoadjuvant chemotherapy in breast cancer patients
Analysis of Treatment and Survival of Occult Breast Cancer with Axillary Lymph Node Metastasis:
Comparisons of Survival Outcomes of the Different Surgical Approaches in Occult Breast Cancer with Axillary Node Metastasis
Expression of the Claudin 1,3,4 and 7 in Triple Negative Breast Cancer : Does Not Correlate with Prognosis
Stage, Biology and Age
Ki 67 Expression and Oncotype DXTM Recurrence Score in Korean Breast Cancer Patients
Examining Bone Degeneration as a Side Effect of Treatment in Premenopausal Breast Cancer Patients
Feasibility of sentinel lymph node biopsy after preoperative systemic chemotherapy in breast cancer patients with FNA-proven axillary lymph node metastasis
Prognostic Factors of Male Breast Cancer
Higher breast density is positively associated with larger tumor size and lymph node metastasis: A cross-sectional study of 910 Korean
The patient underwent axillary lymph node dissection was treated with a mixture of Poloxamer and Alginate (Guardix-SG®) Impact on range of action: Single-institution, prospective, randomized, double-blind investigator pilot study
Analysis of serial circulating tumor cell count during neoadjuvant systemic therapy in breast cancer patients
Clinicopathologic Characteristics and Prognostic factors of pure mucinous breast cancer
THE CLINICAL SIGNIFICANCE OF ANTI-MULLERIAN HORMONE EVALUATION IN BREAST CANCER PATIENTS WHO ARE TAKING TAMOXIFEN.
Screening for Psychological Distress in Breast Cancer Patients and Psychiatric Referral acceptance among Screen Positive Patients
A Nomogram for Predicting the Oncotype DX Recurrence Score in Women with T1-3N0-1miM0 Hormone Receptor-positive, Human Epidermal Growth Factor-2 (HER2)-negative Breast Cancer
Evaluation of Surgical Guides Using a 3D Printer in Breast Cancer Patients Who Received Neoadjuvant Chemotherapy
No negative effect of short-term delays in surgery on tumor progression and survival outcomes in invasive breast cancer.
CHEMOTHERAPY FOR NODE-NEGATIVE, HORMONE RECEPTOR-POSITIVE MUCINOUS CARCINOMA OF BREAST
Breast-specific gamma imaging versus magnetic resonance imaging in ductal carcinoma in situ: A prospective head-to-head trial
Neutrophil lymphocyte ratio(NLR) change after systemic treatment can be a predictive factor of cancer specific survival(CSS) in stage lV breast cancer.
Poor survival of the young breast cancer is due to early and late recurrence in non triple negative breast cancer
Multiple Primary Cancers in Breast Cancer Patients
Discordance of hormone receptor and human epidermal growth factor receptor2 as a prognostic factor of survival between primary breast cancer and recurrent breast cancer.
Heterogeneity of Reproductive Risk Factors for Breast Cancer According to Age and Tumor Subtype
Diagnostic performance of breast scintigraphy with breast-specific gamma camera in the assessment of residual tumor after neoadjuvant chemotherapy in breast cancer patients
Analysis of Treatment and Survival of Occult Breast Cancer with Axillary Lymph Node Metastasis:
Comparisons of Survival Outcomes of the Different Surgical Approaches in Occult Breast Cancer with Axillary Node Metastasis
Expression of the Claudin 1,3,4 and 7 in Triple Negative Breast Cancer : Does Not Correlate with Prognosis
Stage, Biology and Age
Ki 67 Expression and Oncotype DXTM Recurrence Score in Korean Breast Cancer Patients
Examining Bone Degeneration as a Side Effect of Treatment in Premenopausal Breast Cancer Patients
Feasibility of sentinel lymph node biopsy after preoperative systemic chemotherapy in breast cancer patients with FNA-proven axillary lymph node metastasis
Prognostic Factors of Male Breast Cancer
Higher breast density is positively associated with larger tumor size and lymph node metastasis: A cross-sectional study of 910 Korean
영상자료
발표자료
발표자료 내용이 없습니다.